Who
Thomas Haughey
Director
Company insider
Files Form 4 as: Director, ANI Pharmaceuticals; President, Par Pharmaceutical Companies.
In numbers
- Trades disclosed
- 164
- Buys
- 6
- Sells
- 7
- Bought
- $568K
- Sold
- $8.4M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 9 Jan 2006
- Last trade
- 8 Jun 2026
- Last filed
- 10 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Jun 2026filed 10 Jun 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $162K2,000 at $80.88 | filing |
| 8 Jun 2026filed 10 Jun 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $162K2,000 at $80.88 | filing |
| 21 May 2026filed 10 Jun 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —4,357 at $0.00 | filing |
| 21 May 2026filed 10 Jun 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —4,357 at $0.00 | filing |
| 12 Aug 2025filed 14 Aug 2025 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $1.7M19,341 at $85.93 | filing |
| 22 May 2025filed 27 May 2025 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —4,336 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —4,410 at $0.00 | filing |
| 23 May 2023filed 24 May 2023 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —6,865 at $0.00 | filing |
| 27 Apr 2022filed 29 Apr 2022 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —10,049 at $0.00 | filing |
| 6 Dec 2021filed 7 Dec 2021 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Bought | $98K2,500 at $39.38 | filing |
| 23 Mar 2021filed 25 Mar 2021 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —9,292 at $0.00 | filing |
| 10 Apr 2020filed 14 Apr 2020 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —7,119 at $0.00 | filing |
| 4 Mar 2020filed 5 Mar 2020 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Bought | $135K3,000 at $45.05 | filing |
| 3 Mar 2020filed 5 Mar 2020 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Bought | $90K2,000 at $45.18 | filing |
| 15 May 2019filed 15 May 2019 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Bought | $173K2,500 at $69.30 | filing |
| 28 Mar 2019filed 1 Apr 2019 | ANIP ANI Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —2,409 at $0.00 | filing |
| 28 Mar 2019filed 1 Apr 2019 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —1,991 at $0.00 | filing |
| 6 Jun 2018filed 8 Jun 2018 | ANIP ANI Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —2,225 at $0.00 | filing |
| 6 Jun 2018filed 8 Jun 2018 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —1,800 at $0.00 | filing |
| 28 Sep 2012filed 2 Oct 2012 | Par Pharmaceutical Companiesoption or derivative | SEC FORM 4 Code D | $1.3M25,438 at $50.00 | filing |
News
No headline names them, or the companies they trade most, lately.